A

Aldagen, Inc

50 employees

Aldagen develops regenerative cell therapies for inherited metabolic diseases, leukemia, critical limb ischemia and ischemic heart failure.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Stem cell therapeutics
Health Care

Date founded

2001

Funding rounds raised

Total raised

$18M

from 12 investors over 12 rounds

A

Aldagen, Inc raised $18M on April 23, 2008

Investors: Intersouth Partners and Tullis Health Investors

A

Aldagen, Inc raised $9M on September 1, 2007

Investors: Cfa Enterprises Inc, Intersouth Partners and Tullis Health Investors

A

Aldagen, Inc raised $14M on December 19, 2006

Investors: Piedmont Entrepreneurs Network, Intersouth Partners, Tall Oaks Capital and Village Ventures

A

Aldagen, Inc raised $3M on December 19, 2006

Investors: Square 1 Bank

A

Aldagen, Inc raised $4.9M on March 12, 2003

Investors: Intersouth Partners

A

Aldagen, Inc raised $6M on February 1, 2002

Investors: Intersouth Partners

FAQ